03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Carboplatine Mylan 150mg : | |
Type | Medicine Authorised |
Originator | Paraplatin 150mg* |
Agent | Benta Trading Co |
Distributor | Benta Trading Co |
Laboratory | Mylan |
Manufacturer | Benta SAL |
Manufacturing Type | Benta SAL under license from Mylan S.A.S. France |
Origin | Lebanon |
ATC | L01XA02 |
Carboplatine Mylan 150mg :
Carboplatine Mylan 150mg :
Carboplatine Mylan 150mg :
Carboplatine Mylan 150mg :
Carboplatine Mylan 150mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Carboplatine Mylan 150mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Allergic reaction | Common |
Alopecia | Common |
ALT increased | Very Common |
Anaemia | Very Common |
AST increased | Very Common |
Bilirubin total increased | Common |
Blood alkaline phosphatase increased | Very Common |
Blood creatinine increased | Common |
Blood urea increased | Very Common |
Bronchospasm | Rare |
Chills | Common |
Constipation | Common |
Creatinine renal clearance decreased | Very Common |
Diarrhoea (Diarrhea) | Not known |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Fever | Common |
Gastrointestinal pain | Common |
Haemoglobin decreased | Very Common |
Hypoacusis | Very rare |
Hypocalcaemia | Very Common |
Hypokalaemia | Very Common |
Hypomagnesaemia | Very Common |
Hyponatraemia (Hyponatremia) | Very Common |
Hypotension | Rare |
Leucopenia (Leukopenia) | Very Common |
Nausea | Very Common |
Neuropathy peripheral | Common |
Neutropenia | Very Common |
Paraesthesia (paresthesia) | Common |
Pruritus | Common |
Rash erythematous | Common |
Sensory disturbance | Common |
Skin rash | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Urticaria | Common |
Visual disturbance | Common |
Vomiting | Very Common |
Carboplatine Mylan 150mg :
NB : Products With Same Indication |
Different Units By MoH Code
Carboplatine Mylan 150mg MoH 6469 :
Form | Solution for infusion |
Packaging | Vial (Type I Glass) |
Package Size | 1x15ml |
Strength | 150mg |
Storage Condition | <25°C protect from light |
Public Price | 2783658.06 L.L. |
Stratum | B |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 219212/09 |
Submission date | 01/01/2009 |
Registration Year | 2011 |
Price Comparison
● Country: | Lebanon | |
● Form: | Solution for infusion | |
● Package Size: | 1x15ml | |
● Public Price: | 2783658.06 LBP | ( 2,783,658.06 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2783658,06 LBP | ( 2,783,658.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Finland |
● Package Size: | 15ml |
● Reference: | Kela |
● Pricing Date: | 24/10/2020 |
● Type: | Medicine Non Marketed |
● Country: | France |
● Package Size: | 15ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File